- Profile
- Personal Information
- Publications
Experts in Clinical Sciences
Natasha Anandaraj Mark White Susan K Birden MICHAEL BILL Pravir Kumar Roger Badia P.Madhava Soma Sundaram Douglas K. Martin Blaine Y. Takesue Karsten Rebner JEFF ANDERSON Syed Umarhathab R.Sivakumar Enanalap Periyar Amy Berkov Kristin Meyer Nora Stelter A.J.R. Albert Heck Simon Allison BIG ANNA MARIA View MoreRichard T. Dean
Chairman of the Board
Clinical Sciences
Adhaere Pharmaceuticals
United States of America
Dr. Dean is a seasoned Pharma executive. Dr. Dean was a co-founder and CEO of Xanthus Therapeutics and led its successful sale to Antisoma. Previously, he was a co-founder and CEO of Diatide and led its successful IPO and a subsequent sale to Schering. Dr. Dean has also held executive positions with Mallinckrodt, Merck, and Centocor. Dr. Dean earned a B.S. in Chemical Engineering from Cornell University, an M.S. degree in Organic Chemistry from the University of Michigan, and a Ph.D. in Organic Chemistry from the University of California, Berkeley,CA.
Biochemical and Microbial Toxicology